The cation-chloride cotransporter NKCC1 plays a fundamental role in the central and peripheral nervous systems by setting the value of intracellular chloride concentration. Following peripheral nerve injury, NKCC1 phosphorylation-induced chloride accumulation contributes to neurite regrowth of sensory neurons. However, the molecules and signaling pathways that regulate NKCC1 activity remain to be identified. Functional analysis of cotransporter activity revealed that inhibition of endogenously produced cytokine interleukin-6 (IL-6), with anti-mouse IL-6 antibody or in IL-6 Ϫ/Ϫ mice, prevented chloride accumulation in a subset of axotomized neurons. Nerve injury upregulated the transcript and protein levels of IL-6 receptor in myelinated, TrkB-positive sensory neurons of murine lumbar dorsal root ganglia. Expression of phospho-NKCC1 was observed mainly in sensory neurons expressing IL-6 receptor and was absent from IL-6 Ϫ/Ϫ dorsal root ganglia. The use of IL-6 receptor blocking-function antibody or soluble IL-6 receptor, together with pharmacological inhibition of Janus kinase, confirmed the role of neuronal IL-6 signaling in chloride accumulation and neurite growth of a subset of axotomized sensory neurons. Cell-specific expression of interleukin-6 receptor under pathophysiological conditions is therefore a cellular response by which IL-6 contributes to nerve regeneration through neuronal NKCC1 phosphorylation and chloride accumulation.
Introduction
Plasma membrane cation-Cl Ϫ cotransporters are important for setting the intracellular chloride concentration in neurons, and the regulation of their expression or activity has major consequences under physiological and pathophysiological conditions (Blaesse et al., 2009 ). In the adult peripheral nervous system, preferential expression of the inwardly directed Na ϩ -K ϩ -Cl Ϫ cotransporter, NKCC1, is responsible for the high intracellular chloride concentration, [Cl Ϫ ] i , compared with central neurons (Price et al., 2009) . Under physiological conditions, the high [Cl Ϫ ] i confers depolarizing effects to the ligand-activated chloride channel GABA A , which is involved in the inhibitory control of pain (Price et al., 2009) . Following inflammation, occurrence of neurogenic pain is attributed to a further increase [Cl Ϫ ] i , leading to both retrograde and anterograde propagation of electrical activity (Cervero et al., 2003) . In a peripheral nerve injury model, an increase in [Cl Ϫ ] i among regenerating sensory neurons accelerates growth rate of neurites, suggesting that chloride homeostasis plays a major role in nerve repair (Pieraut et al., 2007) . In peripheral neurons, transcriptional modifications, phosphorylation and protein trafficking have been identified as cellular mechanisms responsible for upregulation or downregulation of [Cl Ϫ ] i (Morales-Aza et al., 2004; Galan and Cervero, 2005; Pieraut et al., 2007; Geng et al., 2009) . Consistent with the role of cation-Cl Ϫ cotransporters in pain processing, inflammatory mediators such nerve growth factor, bradykinin or prostaglandin all induce accumulation of chloride (Nakajima et al., 2007; Funk et al., 2008) . Following nerve injury, the signaling molecules that regulate chloride homeostasis of axotomized sensory neurons are unknown. The proinflammatory cytokine, interleukin-6 (IL-6), contributes to the regeneration of afferent fiber, and is thus a potential candidate for regulating chloride homeostasis. Indeed, studies using IL-6 knock-out mice which show defects and delayed regeneration of sensory axons after crush injury, have demonstrated a beneficial function of IL-6 (Zhong et al., 1999) . Combined overexpression of IL-6 and its ␣ receptor IL-6R, IL-6R, resulted in faster regeneration of the hypoglossal nerve (Hirota et al., 1996) . Furthermore, peripheral injury-induced IL-6 is able to promote regeneration within the CNS (Cafferty et al., 2004; Cao et al., 2006) . Since the IL-6 signal-transducing ␤ receptor, gp130, is ubiquitously expressed in sensory neurons, the specificity of IL-6 signaling is mainly mediated by tissue-specific constitutive IL-6 ␣ receptor, IL-6R, expression and/or local actions of soluble IL-6R (Gardiner et al., 2002; Andratsch et al., 2009) . Although the effects of IL-6 are well established in nerve regeneration, the cellular expression of IL-6R in the dorsal root ganglia is unknown. Here, we studied the cellular expression of IL-6R in dorsal root ganglia following nerve injury, and focused on the effects of IL-6 signaling on chloride accumulation, cationCl Ϫ cotransporter expression and phosphorylation.
Materials and Methods
Surgery and cell culture. Adult Swiss and C57BL/6 female mice (6 -8 weeks old, CERJ) and IL-6 Ϫ/Ϫ mice (a gift from S. Hopkins and R. Grencis, University of Manchester, Manchester, UK) (Kopf et al., 1994) , were housed in cages with a 12 h light/dark cycle and fed and water ad libitum. The care and use of the mice conformed with institutional policies and guidelines. Mice were deeply anesthetized by isoflurane inhalation. The left sciatic nerve was exposed at the mid-thigh, sectioned, and a 2-3 mm fragment removed. Five days after surgery, mice were killed by CO 2 inhalation followed by cervical dislocation, and their left lumbar L4-L5 DRGs were removed. Neuronal cultures were established from L4-L5 dorsal root ganglia, as previously described (André et al., 2003) . Dissociated neurons were plated on DL-polyornithine (0.5 mg/ml)-laminin (5 g/ml)-coated glass coverslips and were incubated at 37°C in an incubator with a humidified 95% air/ 5% CO 2 atmosphere.
Genotyping. Genotyping was performed using PCR on extracted DNA. For IL-6 Ϫ/Ϫ mice, the same forward primer (5Ј-TTCCATCCAGTTGC CTTCTTGG-3Ј) was used in combination with reverse primer for the control (5Ј-TTCTCATTTCCACGATTTCCCAG-3Ј) or the mutant gene (5Ј-CCGGAGAACCTGCGTGCAATCC-3Ј).
Measurement of intracellular chloride concentration. Electrophysiological recordings of the ionotropic chloride GABA A current in DRG neurons at 1 d in vitro (DIV) were used to determine reversal potential of chloride current at room temperature as previously reported (Pieraut et al., 2007) . Briefly, the bathing solution contained the following (in mM): 140 tetraethylammonium chloride, 3.5 MgCl 2 , 10 HEPES, and 10 glucose, at pH 7.4 (adjusted with CsOH). Recording pipettes were filled with the following solution (in mM): 145 CsCl, 10 HEPES, 2 Mg-ATP, 0.5 Na 2 -GTP, at pH 7.35 (adjusted with CsOH). Gramicidin-perforated technique was used to determine [Cl Ϫ ] i . Gramicidin A (50 g/ml) (Fluka) was added to the pipette solution. The progress of gramicidin perforation was evaluated by on-line monitoring, with pClamp version 8.2 software (Dipsi Industrie), the capacitive current transient produced by a 10 ms depolarizing voltage step (10 mV) from a Ϫ80 mV holding potential. When the access resistance had dropped to 50 M⍀, puff application of 50 M muscimol activated a chloride current attributable to GABA A receptor activation. The [Cl Ϫ ] i was calculated using the Nernst equation:
, where RT/ZF ϭ 58 mV at room temperature and [Cl Ϫ ] e ϭ 147 mM. All recordings were made using an Axopatch 200B amplifier (Dipsi Industrie).
Interleukin-6 quantification by ELISA. At 1 DIV, supernatant of cultured DRG cells was removed and put at Ϫ80°C. The presence of murine IL-6 in the supernatant was determined by specific ELISAs (BD Biosciences) as previously described (Djouad et al., 2007) . Quantification was performed at least twice. After removal of the supernatant, the glass coverslips were submerged in lysis buffer (50% Ca-and Mg-free PBS and 50% Laemmli lysis buffer) to collect neuronal and non-neuronal cells for protein quantification using photodetection at 280 nm (Biophotometer, Eppendorf).
Immunostaining. Primary antibodies used included the following: mouse anti-glutamine synthetase (Millipore Bioscience Research Reagents; 1:500); goat anti-mouse IL-6 receptor (R&D Systems; extracellular domain, 10 g/ml); rabbit anti-mouse IL-6 receptor (Santa Cruz Biotechnology; C terminus, 1:50); rabbit anti-Neurofilament 200 (Sigma; 1:100 for DRG slice and 1:1000 for culture); rabbit anti-parvalbumin (SWANT;1:10,000). Rabbit anti-phospho-NKCC1 (1:500), directed against the regulatory phosphothreonines Thr 212 and Thr 217 of human NKCC1, was a gift from Dr. B. Forbush (Yale University, New Haven, CT), and specific staining in DRG neurons was demonstrated previously (Pieraut et al., 2007) ; rabbit anti-TrkB (Millipore; 1:1000); and rabbit anti-TrkA (Millipore; 1:500); mouse anti-␤-III tubulin (Sigma; 1:500). Anti-parvalbumin, TrkB and TrkA antibodies were kindly provided by Dr. Patrick Carroll (Institute for Neurosciences, Montpellier, France) (Bourane et al., 2009) . Secondary antibody incubations were performed with Alexa Fluor-594 or Alexa Fluor-488-conjugated secondary antibodies (Invitrogen; 1:1000).
For immunohistochemistry, L4-L5 DRGs were dissected in PBS, fixed for 2 h in 4% paraformaldehyde, immerged overnight in 25% sucrose, and embedded in OCT compound. Frozen DRG sections (14 m) were cut, and each was washed with PBS, blocked with 10% donkey serum, and incubated overnight at 4°C with primary antibodies. For phospho-NKCC1 immunostaining, an epitope-demasking procedure was performed by immersion of sections for 15 min at 68°C in sodium citrate buffer (10 mM sodium citrate, 0.05% Tween 20 at pH 6). After a wash in PBS, DRG sections were incubated for 1 h at room temperature with secondary antibody, and then mounted in Mowiol. They were then overnight incubated at 4°C with the primary antibodies.
Images were collected using either a PL-Apochromat 20ϫ or 40ϫ objective mounted on an upright Zeiss microscope equipped with a CCD camera AxioCam MRm, or an LSM5 confocal microscope (Zeiss). Image acquisition and analysis was done using AxioVision (Zeiss).
Neurite growth analysis. Neurons were seeded in 4-well chambers at a density of 500 neurons per well and maintained in culture medium at 37°C. To make accurate measurements of primary neurite length, analyses were performed 8 h after plating. We previously showed that significant neurite growth at 8 h is exhibited by 55% of neurons after a conditioning lesion compared with 8% of controls (Pieraut et al., 2007) . Cultures were fixed for 15 min in 4% paraformaldehyde in PBS, and incubated for 20 min in 15% donkey serum in PBS. They were then incubated 2 h at room temperature with the primary antibodies (panneuronal ␤-III-tubulin for neurite length measurement and NF-200 as mechano-proprioceptive marker). After a wash in PBS, cultures were incubated for 1 h at room temperature with secondary antibodies, and were mounted in Mowiol. Images were collected using a PL-Apochromat 10ϫ objective and ImageJ was used for somatic diameter and neurite analysis. Soma that extended neurites (primary neurite) greater than two cell body diameters were analyzed. Measurements were calculated from at least three wells, with three mice per experimental group.
Quantification of mRNA expression levels by reverse transcriptasequantitative PCR. Total mRNA was extracted from lumbar L4-L5 DRGs of adult mice using the RNeasy Mini Kit (Qiagen) in accordance with the manufacturer's instructions. Briefly, DRGs were harvested in RNAlater stabilization buffer (Qiagen) and homogenized by passing the lysate 10 times through a 20 gauge needle. Lysates were then mixed with an equal volume of 70% ethanol, and total mRNA was separated from other cellular components using RNeasy minispin columns. The eluted mRNA was quantified using spectrophotometry (Nanodrop; Labtech). Reverse transcription was performed with 1 g of mRNA using the Quantitect RT kit (Qiagen) and the following thermal cycling protocol: 60 min at 37°C; 5 min at 95°C. cDNA was then collected and stored at Ϫ20°C until further use. Primers were designed with Primers 3.0 software. Sequences for all primers are shown in Table 1 . Quantitative PCR was performed at least three times on duplicate samples of cDNA diluted to 1:10 using SYBR Green (Qiagen) for detection on the LightCycler system (Roche Diagnostics). After an initial activation step of 15 min at 95°C, 45 amplification cycles were performed consisting of 94°C for 15 s, 59°C for 20 s and 72°C for 35 s. After PCR amplification, a melting curve analysis was generated to check the specificity of the PCR. The identity of reverse transcriptase (RT)-PCR-amplified products was confirmed by sequencing (MilleGen). Polymerase (RNA) II polypeptide J, Polr2J, levels were used to normalize amounts of cDNA (Pieraut et al., 2007 (Pieraut et al., 2007) . To determine whether IL-6 was involved in chloride accumulation, we first analyzed the effects of nerve injury on Il6 gene expression in DRG. At 3 d postinjury, the normalized expression of IL-6 mRNA in injured L4-L5 DRGs (1.45 Ϯ 0.06, n ϭ 4) was approximately three orders of magnitude higher than in control L4-L5 DRGs (0.50 Ϯ 0.08, n ϭ 4, Fig.  1A ). We next quantified its production in the culture supernatant of DRG neurons using ELISA. At 1 DIV, the amount of IL-6 in the culture medium of axotomized DRG cultures (n ϭ 6), was 78 Ϯ 12 pg/ml ( Fig. 1 B) . We failed to detect IL-6 secretion in DRG primary cultures from IL-6 Ϫ/Ϫ mice, thus demonstrating the specificity of the ELISA test (n ϭ 2, data not shown). DRG primary cultures contain both neurons and non-neuronal cells. To assess the neuronal contribution to IL-6 secretion relative to nonneuronal cells, we performed IL-6 measurements in axotomized culture at 4 DIV in the absence and the presence of 1 M (␤-Darabinofuranosyl)cytosine, AraC, to reduce non-neuronal cell proliferation. In agreement with a continuous IL-6 production and secretion in vitro with time (Cao et al., 2006) , the amount of IL-6 was increased to 397 Ϯ 33 pg/ml (n ϭ 3) at 4 DIV. In the presence of AraC, it was reduced to 277 Ϯ 10 pg/ml (n ϭ 3) ( Fig.  1 B) . Consistent with cell proliferation and growth, protein content was significantly increased at 4 DIV compared with 1 DIV, and AraC decreased it to level similar to 1 DIV (Fig. 1C) . From these data, it appeared that probably both neurons and nonneuronal cells contribute to IL-6 production in vitro.
We next assessed whether the [Cl Ϫ ] i , was controlled by endogenously produced IL-6 by measuring the reversal potential of the ligand-gated Cl Ϫ current GABA A , E GABA A in sensory neurons (Fig. 1 D) . We first focused our study on neurons having a somatic diameter Ͼ30 m to discriminate mechanoproprioceptors from nociceptors. As previously shown, E GABA A of axotomized sensory neurons was shifted toward depolarized potentials following nerve injury (from Ϫ41.8 Ϯ 1.0 mV, n ϭ 16, in control neurons to Ϫ26.5 Ϯ 1.3 mV, n ϭ 14, in axotomized neurons). This corresponded to a twofold increase in [Cl Ϫ ] i ( Fig. 1 E) .
To verify whether IL-6 was involved in the [Cl Ϫ ] i increase observed in axotomized neurons, we performed experiments using a blocking-function IL-6 antibody to neutralize secreted IL-6 in conditioned cultures. Following dorsal root ganglia dissociation, antibodies raised against mouse IL-6 (mIL-6) or human IL-6 (hIL-6) were added to the culture (10 g/ml each) and incubated overnight before electrophysiological recordings. The reversal potential of GABA A current of axotomized neurons was significantly shifted to hyperpolarized values in cultures treated with mIL-6 antibody (Ϫ41.2 Ϯ 2.5 mV, n ϭ 11, Fig. 1 E) . However it did not change in axotomized neurons treated with hIL-6 antibody (Ϫ25.1 Ϯ 2.5 mV, n ϭ 7). Analysis of chloride homeostasis in IL-6 Ϫ/Ϫ mice shows no significant differences in the reversal potential of the GABA A current in control neurons from IL-6 ϩ/ϩ (Ϫ41.3 Ϯ 1.9 mV, n ϭ 6) and IL-6 Ϫ/Ϫ mice (Ϫ47.3 Ϯ 2.6 mV, n ϭ 6, Fig. 1 F) . Experiments performed on axotomized neurons showed that E GABA A was significantly less depolarized in IL-6 Ϫ/Ϫ neurons (Ϫ36.6 Ϯ 1.9 mV, n ϭ 13) than in IL-6 ϩ/ϩ neurons (Ϫ25.4 Ϯ 1.5 mV, n ϭ 10, p Ͻ 0.001). Following nerve injury, the increase in [Cl Ϫ ] i was significantly less in IL-6
neurons than in wild-type neurons ( Fig. 1 F) . These findings indicate that endogenously produced IL-6 regulates [Cl Ϫ ] i in regenerating axotomized sensory neurons.
Nerve injury upregulates IL-6 ␣ receptor expression in dorsal root ganglia neurons
To examine whether specific changes in transcript levels of IL-6 ␣ receptor, IL-6R, were associated with the increase in IL-6 following sciatic nerve injury in vivo, we conducted RT-qPCR on control and axotomized L4-L5 DRG. Our data show that Il6ra mRNA levels varied with injury. Remarkably, injury induced a twofold increase in mRNA expression of Il6ra in DRG (from 0.75 Ϯ 0.05 to 1.49 Ϯ 0.04, n ϭ 7, Fig. 2 A) .
We next addressed with immunofluorescence microscopy whether expression of IL-6R protein was also increased in axotomized DRG. Immunohistochemistry using an antibody raised against the extracellular domain of mouse IL-6R revealed staining close to the plasma membrane in 5% of neurons from control DRG (60/1142, Fig. 2 B) . In contrast, the number of neurons expressing a clear IL-6R stained ring was substantially increased in axotomized DRG (305/1303, 23%, p Ͻ 0.01, 2 test, Fig. 2 B) . The specificity of staining in axotomized DRG was assessed by incubating the antibody with the soluble IL-6R before immunostaining. Under this condition, no signal could be detected at the level of plasma membrane (Fig. 2C ). Experiments using a second IL-6R antibody raised on the C-terminal domain confirmed signal specificity at the level of plasma membrane (Fig. 2C) . Although the expression of IL-6R is well established among glial cells, neuronal expression of IL-6R has not been reported. To determine the cellular identity of IL-6R-positive cells, we performed double labeling experiments with anti-IL-6R antibody and anti-glutamine synthetase antibody, a marker of satellite glial cells. These experiments revealed that glutamine synthetase staining was surrounding IL-6R staining which supports a neuronal expression pattern for IL6-R at/close to the neuronal membrane (Fig. 2 D) . These results demonstrate that nerve injury upregulates expression of IL-6R transcript and induces IL-6R protein expression at/close to the neuronal plasma membrane of a subset of DRG neurons. 
IL6-R is expressed in a subset of mechano-and proprioceptive sensory neurons in vivo
To identify the class of sensory neurons expressing IL-6R in axotomized DRG, we first performed a series of double labeling experiments by monitoring the coexpression of IL-6R with NF-200, a biochemical marker of myelinated sensory neurons. Most IL-6R-positive neurons expressed NF-200 (92%, 56/61), thus identifying them as part of the myelinated population (Fig. 3A) . To further confirm the functional identity of this neuronal subpopulation, we performed double labeling experiments with TrkB, the high affinity receptor for brain-derived neurotrophic factor and neurotrophin-4. TrkB is expressed in subsets of myelinated mechanoreceptors. Most IL-6R-positive neurons coexpressed TrkB (67/84, 80%) (Fig. 3B) . As we failed to get a clear staining with rabbit anti-TrkC antibody, we used anti-Parvalbumin antibody and found that approximately 30 -40% of IL-6R coexpressed this proprioceptive marker (37/107) (Fig. 3C ). In agreement with IL-6R expression among mechanoproprioreceptors, no overlap was observed between IL-6R and TrkA, a high affinity receptor for nerve growth factor that specifically marks a subset of nociceptive neurons (1/61, 2%) (Fig. 3D) . From these results, we conclude that nerve injury induces expression of IL6-R in vivo among mechano-and proprioceptive sensory neurons.
IL-6R expression in large somatic-sized axotomized neurons is responsible for intracellular chloride regulation through the JAK/STAT pathway
To test whether the effects of IL-6 were mediated through neuronal expression of its cognate receptor IL-6R, we assessed IL-6R expression in neuronal primary cultures from axotomized DRG. Immunocytochemistry with the anti-IL-6R antibody confirmed the expression of IL-6R among medium-to large-sized axotomized sensory neurons (Fig. 4 A) . In agreement with the in situ immunofluorescence results, the population of stained neurons having in vitro a somatic diameter Ͼ30 m is representative of mechanoproprioceptive sensory neurons and accounted for 34% of the total population (228/883). Expression of IL-6R was not observed among most of the nociceptors that are characterized in vitro by a somatic diameter smaller than 30 m. Moreover, no expression was observed among nonneuronal cells.
Having determined that IL-6R is specifically expressed in medium-to largesized axotomized neurons, we analyzed, among this subset of neurons, the effects of the blocking-function IL-6R antibody and of the soluble IL-6R on the [Cl Ϫ ] i . Following overnight incubation with 10 g/ml anti-IL-6R antibody, E GABA A was significantly less depolarized than in untreated neurons (Ϫ47.2 Ϯ 2.6 mV, n ϭ 15 versus Ϫ23.5 Ϯ 1.9 mV, n ϭ 8, p Ͻ 0.001, Fig. 4 B) . The soluble IL-6R competes with its membrane-bound counterpart for ligand binding and therefore could act as an antagonist in cells expressing IL-6R . Consistent with antagonistic effects, E GABA A was significantly less depolarized following soluble IL-6R treatment (Ϫ49.8 Ϯ 2.0 mV, n ϭ 6, p Ͻ 0.001). To further confirm the cell ) . B, Quantitative ELISA measurements of IL-6 production in primary cultures of axotomized neurons from L4 -L5 DRGs were performed at days 1 and 4 in vitro. The AraC-sensitive IL-6 production accounted for approximately 30% of total secretion at 4 DIV (**p Ͻ 0.01, ***p Ͻ 0.001; one-way ANOVA). C, Corresponding protein content measurements show a significant protein content increase at 4 DIV which was prevented in the presence of 1 M AraC. (*p Ͻ 0.05; one-way ANOVA). D, Gramicidin-perforated patch recordings were used to determine [Cl Ϫ ] i in sensory neurons. Ramp protocols from Ϫ80 mV to ϩ40 mV were applied every 5 s in a Ca-free, Na-free, K-free, 147 mM tetraethylammonium-Cl extracellular solution. Activation of chloride current GABA A with puff application of 50 M muscimol allowed for determination of reversal potential, E GABA A , of the chloride current and to calculate intracellular chloride concentration (see Materials and Methods). E GABA A was Ϫ25 mV in an axotomized sensory neuron, and calculated [Cl Ϫ ] i was 54 mM. E, Following axotomy, sensory neurons increase their [Cl Ϫ ] i from 28.3 Ϯ 1.1 mM to 52.3 Ϯ 2.8 mM (***p Ͻ 0.001, t test). Incubation of axotomized neurons with 10 g/ml anti-mouse IL-6 antibody, mIL-6 Ab, significantly decreased [Cl Ϫ ] i to 30.0 Ϯ 2.8 mM. Incubation with 10 g/ml hIL-6 Ab, which does not cross-react with the murine IL-6, had no effect on the [Cl Ϫ ] i of axotomized neurons that amounted to 55.8 Ϯ 5.2 mM (***p Ͻ 0.001; one-way ANOVA between axotomized conditions). F, E GABA A recordings from IL-6 ϩ/ϩ and IL-6 Ϫ/Ϫ sensory neurons show no significant difference in [Cl Ϫ ] i under control conditions, which averaged 29 Ϯ 2 mM and 23 Ϯ 2 mM, respectively. The main effect of IL-6 deletion was associated with axotomy. [Cl Ϫ ] i was significantly higher in axotomized IL-6 ϩ/ϩ sensory neurons (54.5 Ϯ 3.2 mM) than in IL-6 Ϫ/Ϫ axotomized sensory neurons (35 Ϯ 3 mM) (**p Ͻ 0.01, ***p Ͻ 0.001; two-way ANOVA). Number of experiments is in brackets.
specificity of IL-6R expression, small axotomized neurons with a somatic diameter Ͻ30 m were recorded in the presence of function-blocking anti-IL-6R antibody. Following axotomy, these neurons show chloride accumulation similar to medium to large neurons. However, anti-IL-6R antibody incubation did not significantly alter E GABA A , which averaged Ϫ20.2 Ϯ 2.2 mV in axotomized neurons (n ϭ 5) and Ϫ19.0 Ϯ 1.8 mV in axotomized neurons treated with anti-IL-6R antibody (n ϭ 7, Fig. 4C) .
Finally, the functional implication for the regulation of chloride homeostasis of the downstream Janus kinase signaling initiated by IL-6R activation was investigated in medium to large neurons. We used three pharmacological inhibitors of these pathways, AG490, cucurbitacin and a specific Jak1-2 inhibitor, INCB 018424 (Quintás-Cardama et al., 2010). Following overnight incubation, these inhibitors shifted E GABA A among axotomized neurons toward hyperpolarized potentials from Ϫ17.5 Ϯ 3.2 mV (n ϭ 14) to Ϫ33.2 Ϯ 1.3 mV (n ϭ 11) for AG490; Ϫ41.9 Ϯ 4.5 mV (n ϭ 10) for cucurbitacin and Ϫ38.0 Ϯ 1.3 mV (n ϭ 11) for INCB (Fig. 4 D) . Our data support that signaling through neuronal IL-6R regulates [Cl Ϫ ] i in medium-to large-sized sensory neurons following peripheral nerve injury.
IL-6 signaling promotes NKCC1 phosphorylation on plasma membrane in vivo
We previously reported that axotomy does not modify NKCC1 transcript expression (Pieraut et al., 2007) . The contribution of the outwardly directed cation-Cl Ϫ cotransporters (KCC1-4) to the regulation of [Cl Ϫ ] i in sensory neurons is unknown. We therefore used RT-qPCR to screen for the expression of KCC1-4 transcripts in control DRG and following nerve injury. Analysis of the relative expression of cation-Cl Ϫ cotransporters in DRG shows a preferential transcript expression of NKCC1, KCC1, and KCC3 (Fig. 5A ). Three days after axotomy, no significant change in transcripts encoding the five Slc12a genes was observed (Fig. 5B) . Gene expression analysis performed in DRG from IL-6 Ϫ/Ϫ mice showed no significant changes in the relative expression of cotransporters (data not shown), and nerve injury did not significantly modify them (Fig. 5B) . Our gene expression analysis thus confirms that transcriptional modification of cation-Cl Ϫ cotransporters cannot account for the effects of IL-6 on intracellular chloride concentration.
We previously shown that NKCC1 phosphorylation is a major contributor to [Cl Ϫ ] i regulation following nerve injury (Pieraut et al., 2007) . To assess whether IL-6 signaling is responsible for NKCC1 phosphorylation, we performed phospho-NKCC1 labeling in WT and IL-6 Ϫ/Ϫ DRG. In control DRG from WT mice, no distinctive staining was observed among sensory neurons (Fig. 6A) . Five days following nerve injury, an intense phospho-NKCC1 staining was observed close to the plasma membrane of a subset of sensory neurons (Fig. 6B) . Analysis of phospho-NKCC1 expression in control IL-6 Ϫ/Ϫ DRG was similar to WT, with no obvious staining (Fig. 6C ). In contrast with WT DRG, phospho-NKCC1 staining was no longer detected in IL-6 Ϫ/Ϫ sensory neurons after nerve injury (Fig. 6D) . The neuronal expression of phospho-NKCC1 in axotomized sensory neurons was confirmed by colabeling with the glial marker glutamine synthetase (Fig. 6E ). In addition, double labeling with IL-6R established its coexpression with phospho-NKCC1 in a subset of DRG sensory neurons (Fig. 6F) . These data imply that IL-6 promotes expression of phospho-NKCC1 at or close to the plasma membrane of axotomized sensory neurons expressing IL-6R.
IL-6 signaling contributes to neurite growth promoting effects of NKCC1
Previously, we reported that NKCC1 is involved in determining the velocity of elongated growth of axotomized neurons (Pieraut et al., 2007) . To uncover whether regulation of NKCC1 through IL-6 signaling was involved in neurite growth of NF-200-positive large neurons, neuronal cultures from axotomized DRG were processed for NF-200 and ␤-III-tubulin immunocytochemistry. Somatic diameter and associated neurite growth were recorded for neurons that were distinguishable from their neighbors and ) . B, Images of transverse sections of L4 -L5 DRGs immunolabeled with an antibody generated against a recombinant extracellular domain of mouse IL-6R (10 g/ml; red, Alexa 594). In control DRG, minor staining of IL-6R is evident at/close to the neuronal plasma membrane (arrowhead). In axotomized DRG, a plasma membrane staining is observed more frequently in a subset of sensory neurons (arrowhead). C, Preincubation of 10 g/ml anti-IL-6R antibody with 100 g/ml soluble IL-6R for 2 h at 4°C prevented the plasma membrane staining of IL-6R in axotomized DRG (left). Right, labeling of axotomized DRG with an anti-IL6R antibody raised on the intracellular C-terminal is also observed at/close to the neuronal plasma membrane (arrowhead). D, Confocal images of transverse section of axotomized L4 -L5 DRGs costained with anti-IL-6R (extracellular) and anti-glutamine synthetase (GS, a satellite cell marker) antibodies. DAPI shows the nucleus of cells surrounding neurons (note that neuronal nucleus is not observed at this stack level). The merge image shows satellite cells staining surrounding neuronal IL-6R staining (inset is 3ϫ magnification of membrane portion, shown with an asterisk). Scale bars, 30 m.
analyzed according to their NF-200 expression and somatic size (Fig. 7A) . For each neuron, the number of primary neurites expanding from the soma and the corresponding total maximal length were analyzed by using pan-neuronal ␤-III-tubulin staining. We show that large-sized sensory neurons (soma Ͼ30 m) were NF-200 positive and characterized a higher number of primary neurites and a longer total length (3.3 Ϯ 0.3 neurites/neuron and 1130 Ϯ 119 m, n ϭ 26) compared with NF-200-positive or -negative small-sized neurons (soma Ͻ30 m, 2.0 Ϯ 0.2 neurites/ neuron and 679 Ϯ 78 m, n ϭ 26; p Ͻ 0.01, t tests) (Fig. 7E,F) .
To ensure that, in our culture conditions, IL-6 signaling regulates neurite growth in a subset of neurons, 10 g/ml IL-6R blocking-function antibody was added at the time of plating. Under this condition, there was a significant 40% decrease in the total length of primary neurites in large-sized neurons without effects on neurite number (733 Ϯ 86 m and 3.1 Ϯ 0.5 neurites/neuron, n ϭ 38; Fig.  7 B, E) . No significant effects of IL-6R blocking-function antibody were observed in the length and number of primary neurites in small-sized neurons (721 Ϯ 81 m and 2.3 Ϯ 0.3 neurites/ neuron, n ϭ 27; Fig. 7F ). Consistent with its inhibitory effects on Jak1-2, incubation with 300 nM INCB 018424 reduced by 50% total primary neurite length of largesized neurons without effects on neurite number (607 Ϯ 78 m and 2.6 Ϯ 0.4 neurites/neuron, n ϭ 25; Fig. 7C ,E). INCB did also significantly decreased neurite length of small-sized neurons without effects on neurite number (422 Ϯ 55 m and 1.8 Ϯ 0.2 neurites/neuron, n ϭ 35; Fig. 7F ). Last, analysis of neurite growth from IL-6 Ϫ/Ϫ DRG culture showed no significant effects of gene deletion on neurite length and number in large-sized neurons (30% decrease to 804 Ϯ 113 m and 2.6 Ϯ 0.4 neurites/neuron, n ϭ 21; Fig. 7 D, E) and in small-sized neurons (609 Ϯ 58 m and 1.5 Ϯ 0.1 neurites/neuron, n ϭ 20; Fig.  7F ). Our data demonstrate that inhibition of IL-6 signaling reduces neurite growth of large-sized NF200-positive axotomized sensory neurons, while Il-6 gene deletion leads to moderate changes in neurite phenotype.
Last, to uncover whether IL-6 signaling was contributing to neurite growth promoting effects of NKCC1, we analyzed IL-6 signaling under NKCC1 inhibition. Low external Cl Ϫ concentration or bumetanide were used to inhibit NKCC1 activity. Consistent with their effects on neurite growth velocity (Pieraut et al., 2007) , low external Cl Ϫ concentration (12 mM instead of 150 mM) or 10 M bumetanide significantly decreased primary neurite length from 1130 Ϯ 119 m (n ϭ 26) to 605 Ϯ 73 m (n ϭ 21) and 471 Ϯ 46 m (n ϭ 17), respectively (Fig. 8 A, C,E,F) . Number of primary neurites was not significantly different from untreated axotomized neurons (3.3 Ϯ 0.3 neurites/neuron, n ϭ 26) and amounted 2.4 Ϯ 0.2 neurites/neuron (n ϭ 21) and 2.6 Ϯ 0.3 neurites/neuron (n ϭ 17), respectively (ANOVA). Addition of 10 g/ml IL-6R blocking-function antibody to the low Cl Ϫ medium (Fig. 8 B, E) or to bumetanide-treated cultures (Fig.  8 D, F ) did not lead to further decrease in neurite length (708 Ϯ 71 m, n ϭ 29 and 486 Ϯ 49 m, n ϭ 22, respectively) and did not modify the number of neurites (2.8 Ϯ 0.2 neurites/ neuron, n ϭ 29 and 2.4 Ϯ 0.2 neurites/neuron, n ϭ 22, respectively).
Discussion
The present study reports that the cytokine, interleukin-6 and its nonsignaling receptor, IL-6R, are upregulated following peripheral nerve injury, in a subset of mechano-and proprioceptive DRG sensory neurons. IL-6 signaling among axotomized neurons expressing IL-6R is responsible for the increase in [Cl Ϫ ] i and the expression of phospho-NKCC1 on the plasma membrane of axotomized sensory neurons. The contribution of NKCC1 to primary neurite growth in medium to large sensory neurons is mediated through IL-6 signaling.
Several functional and morphological studies demonstrated that DRG neurons do not express IL-6R under physiological conditions (Gadient and Otten, 1996; Thier et al., 1999) (Wang et al., 2009) . These results are consistent with data showing that for many neuronal cells, particularly in nociception processing, IL-6 responses depend on trans-signaling due to the presence of soluble IL-6R (Jones et al., 2001; Obreja et al., 2005 ). The present study shows that DRGs express IL-6R mRNA and injury further increases its expression. Nerve injury induced expression of the protein at the plasma membrane of sensory neurons both in vivo and in vitro. Interestingly, we observed that under our experimental conditions, soluble IL-6R inhibited Cl Ϫ accumulation which could be attributed to competition for Il-6 binding with endogenously expressed IL-6R at plasma membrane .Consistent with a regulated expression of IL-6R, protein upregulation has also been reported in hypoglossal neurons and Schwann cells after injury (Hirota et al., 1996; Ito et al., 1998; Lara-Ramírez et al., 2008 ). In a model of pain induced by chronic nerve constriction, increased expression of IL-6R was localized in satellite cells surrounding sensory neurons (Dubový et al., 2010) . 30 m) . B, Following overnight incubation of axotomized primary culture with 10 g/ml anti-IL-6-R antibody, the [Cl Ϫ ] i of axotomized neurons with a somatic diameter Ͼ30 m was significantly lower (24.3 Ϯ 2.6 mM) than nontreated, axotomized neurons (54.5 Ϯ 4.1 mM), and no different from control values (28.0 Ϯ 1.7 mM). Axotomized neurons incubated with 100 ng/ml soluble IL-6R (sIL-6R) have a significantly lower [Cl Ϫ ] i than untreated counterparts (20.6 Ϯ 1.6 mM) (***p Ͻ 0.001; one-way ANOVA). C, Analysis of [Cl Ϫ ] i among sensory neurons with a somatic diameter Ͻ30 m shows that axotomy induced a significant increase in [Cl Ϫ ] i from 24.9 Ϯ 1.1 mM in controls to 66.9 Ϯ 5.7 mM in axotomized neurons, and to 70.2 Ϯ 5.1 mM in anti-IL-6R antibody-treated axotomized neurons, with no differences between treated and nontreated axotomized neurons (***p Ͻ 0.001; one-way ANOVA). D, Jak1-2 inhibitors, AG490 at 50 M, cucurbitacin at 3 M, and INCB 018424 at 300 nM significantly reduced [Cl Ϫ ] i in medium to large axotomized neurons from 52.3 Ϯ 2.8 mM to 39.9 Ϯ 2.0 mM, 32.2 Ϯ 5.7 mM, and 32.9 Ϯ 1.6 mM, respectively (**p Ͻ 0.01, ***p Ͻ 0.001, one-way ANOVA; number of experiments in brackets). Here, we show no colocalization between satellite cell markers and IL6-R. Moreover, in addition to studies showing that sensory neurons express IL-6 in situ and in vitro (Murphy et al., 1995; Thier et al., 1999) , our in vitro data support that neurons are the main source of IL-6 secretion, confirming that nerve injury induces an autocrine neuronal IL-6 signaling.
Our data demonstrate that only a subpopulation of axotomized sensory neurons expresses IL-6R. This subpopulation belongs to the NF-200-positive DRG sensory neurons and expresses TrkB and parvalbumin, known markers of mechano-and proprioreceptors.
In vitro experiments confirm IL-6R expression mainly among the medium and large somatic-diameter neurons, with, however, a somewhat higher percentage (34% versus 23%) of positively stained neurons than in in situ experiments. No IL-6R staining was observed in TrkApositive neurons, suggesting that expression is not present in nociceptive neurons. However, correlations do exist between IL-6 signaling and pain processing, even in the absence of soluble IL-6R. It has been reported that IL-6 and NGF have synergistic effects on nociceptive plasticity (Cafferty et al., 2004; Melemedjian et al., 2010) . It is therefore possible that NGF promotes expression of IL-6R in TrkA-expressing neurons, and long-term primary culture could also induce IL-6R expression in nociceptors (von Banchet et al., 2005) . In these experiments, it is also possible that exogenous IL-6 exerted paracrine neuronal effects. Following axotomy, we report that small somaticdiameter neurons also increased their [Cl Ϫ ] i , which is unrelated to IL-6R activation. The receptor for leukemia inhibitory factor is upregulated in a subset of nociceptive neurons following nerve injury. It is involved in nerve regeneration of small diameter sensory neurons and could be responsible for Cl Ϫ accumulation in nociceptive neurons (Cafferty et al., 2001; Gardiner et al., 2002) . Cell-specific regulation of receptor expression appears to be a major event in the control cellular responses to nerve injury and repair.
We provide evidence that in DRG, the most expressed transcripts of cation-Cl Ϫ cotransporters from the Slc12a gene family code for NKCC1, KCC1, and KCC3. As previously shown, axotomy did not modify gene expression of NKCC1, and here we also shown that the expression of the four outward KCCs was unchanged. RTqPCR in DRG does not discriminate between neuronal subpopulations. Therefore, we also performed transcriptional analysis of cotransporter expression in DRG from IL-6 Ϫ/Ϫ mice and also found no significant modification. Actually, our data show that IL-6 promotes the expression of phospho-NKCC1 on the plasma membrane of DRG neurons expressing IL-6R. Unexpectedly, most small sensory neurons did not express phospho-NKCC1. This could be due to different cellular mechanisms leading to Cl Ϫ accumulation in nociceptors, such as an inhibition of the outwardly directed cation-Cl , in hNKCC1 and mNKCC1) (Flemmer et al., 2002) . A phosphopeptide generated against three phosphorylated sites of hNKCC1 (Thr 203 , Thr 207 , and Thr
212
) was used to demonstrate NKCC1 phosphorylation in small nociceptive neurons exposed to inflammatory agents (Funk et al., 2008) . This immediately questioned the identity of the kinases recognizing these threonines. The sequence of Figure 6 . Il-6 regulates the expression of phospho-NKCC1 close to the plasma membrane of axotomized DRG neurons. A, Transverse section of L4 -L6 DRG immunolabeled with an antibody generated against phospho-NKCC1; no signal is observed. B, Five days after nerve injury, phospho-NKCC1 staining is present at/over the plasma membrane in a subset of sensory neurons (arrows). C, Similar to WT DRG, phospho-NKCC1 staining was absent in transverse sections of L4 -L6 DRGs from IL6 Ϫ/Ϫ mice. D, Five days after nerve injury, only a few neurons have a plasma membrane showing phospho-NKCC1 staining in DRG from IL-6 Ϫ/Ϫ mice (arrow). E, Confocal microscopy of double-immunofluorescent labeling for phospho-NKCC1 (p-NKCC1) and glutamine synthase (GS) shows no coexpression. F, Confocal microscopy of double-immunofluorescent labeling for p-NKCC1 and IL-6R shows expression in the same cell type. Merge image shows a co expression that appears as an alternate punctiform staining at the plasma level. Scale bars, 30 m. Insets in merge images are 3ϫ magnifications of the region marked by white asterisk. A-D, 20ϫ objective; E, F, 40ϫ objective. events leading to NKCC1 phosphorylation involves numerous kinases (Flatman, 2002) . In particular the osmosensors Ste-20 related proline-alanine-rich kinase (SPAK) and the oxidative-stress response 1 kinase (OSR1) are involved (Delpire and Austin, 2010) . Both of these kinases are under the control of upstream kinases such as the kinases with no lysine (WNK) (Kahle et al., 2010 (Vitari et al., 2006) . As the antiphosphopeptide antibody used in our study is generated against Thr 212 and Thr
217
, this does not support a phosphorylation based exclusively on SPAK or OSR1 activity on NKCC1 following nerve injury. The sequence of intracellular events linking IL-6 signaling to the expression of phospho-NKCC1 is currently unknown. In addition to regulating activation or expression of specific kinase, IL-6 could also act by inhibiting the activity of phosphatase, leading to increased phosphorylation and NKCC1 activity (Darman et al., 2001; Pieraut et al., 2007) .
The use of the selective Jak1-2 inhibitor provides evidence that neurite growth of conditioned axotomized neurons is under the dependence of cytokine receptors including the neuropoietic cytokines ciliary neurotrophic factor, IL-6, IL-10, IL-11, IL-22, LIF, oncostatin-M (Murray, 2007) . In agreement with other studies, we show that IL-6 is one of the factors promoting neurite growth (Cafferty et al., 2004; Cao et al., 2006) . In addition, we provide evidence that inhibition of IL-6R signaling specifically reduced total primary neurite length of NF-200-positive medium to large sensory neurons. Contradictory results concerning the effects of IL-6 on neurite growth of conditioned axotomized neurons have been reported using IL-6 Ϫ/Ϫ mice (Cafferty et al., 2004; Cao et al., 2006) . In our culture conditions, we did also get contradictory results as only mild changes in neurite length were obtained in IL-6 Ϫ/Ϫ axotomized sensory neurons. This could be attributed to upregulation of overlapping functions with other neuropoietic cytokine receptors mediated by the common cytokine receptor subunit gp130. Indeed, IL-6 plays roles in neuronal survival and differentiation (März et al., 1997; Thier et al., 1999; Murphy et al., 2000) and Il6 gene deletion does not induce neuronal death (Cafferty et al., 2004) . Consistent with redundancy, mice lacking individual members of IL-6 cytokine family display only mild phenotypes, as also observed in the present work, while animals lacking gp130 are not viable (Betz et al., 1998) . The downstream targets of IL-6 leading to improved neurite growth are poorly Ϫ concentration in the absence (A) and in the presence of 10 g/ml anti-IL-6R blocking-function antibody (B), in control culture medium containing 10 M bumetanide without (C), and in the presence of 10 g/ml anti-IL-6R blocking-function antibody (D). Scale, bar 100 m; 10ϫ objective). E, Analysis of total length of primary neurites in mediumto large-sized axotomized neurons shows a significant decrease in a low external Cl Ϫ concentration (140 mM Na-methanesulfonate, 2 mM CaCl 2 , 1.5 mM MgCl 2 ,5mM KCl, 10 mM glucose, and 10 mM HEPES). The addition of anti-IL-6R blocking-function antibody to the low external Cl Ϫ solution does not induce significant effects (**p Ͻ 0.01, ***p Ͻ 0.001; one-way ANOVA). F, Analysis of total length of primary neurites in medium-to large-sized axotomized neurons shows a significant decrease in axotomized neurons treated with bumetanide. The addition of anti-IL-6R blocking-function antibody to bumetanide-treated culture does not induce significant effects (***p Ͻ 0.001, one-way ANOVA).
known. Studies on gene expression profiling induced with exogenous application of IL-6/IL6R in embryonic DRG cells and PC12 cells point out the recruitment of many growth factors acting as autocrine or paracrine factors (Zhang et al., 2007; Kunz et al., 2009 ). Our results demonstrate that IL-6-induced Cl Ϫ accumulation through NKCC1 phosphorylation is a necessary downstream cellular step which promotes neurite growth in mechano-and proprioceptive neurons.
In conclusion, the present study provides new mechanistic insights into the regulation of chloride homeostasis, and establishes IL-6 signaling through neuronal IL-6R expression as a major regulator of chloride homeostasis among injured myelinated sensory neurons. Our study also opens new perspectives into the molecular partners involved in chloride regulation, especially within the nociceptive versus mechanoceptive sensory neurons.
